Business Description
Terns Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US8808811074
Share Class Description:
TERN: Ordinary SharesDescription
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 436.88 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 4 | |||||
| 3-Year EPS without NRI Growth Rate | 10.4 | |||||
| 3-Year FCF Growth Rate | 10.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.02 | |||||
| 9-Day RSI | 54.13 | |||||
| 14-Day RSI | 51.43 | |||||
| 6-1 Month Momentum % | 49.15 | |||||
| 12-1 Month Momentum % | -59.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.39 | |||||
| Quick Ratio | 22.39 | |||||
| Cash Ratio | 22.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -41.6 | |||||
| Shareholder Yield % | -7.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -33.35 | |||||
| ROA % | -31.8 | |||||
| ROIC % | -1850.81 | |||||
| ROC (Joel Greenblatt) % | -7367.67 | |||||
| ROCE % | -37.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.41 | |||||
| Price-to-Tangible-Book | 1.41 | |||||
| EV-to-EBIT | -0.94 | |||||
| EV-to-Forward-EBIT | -0.98 | |||||
| EV-to-EBITDA | -0.95 | |||||
| EV-to-Forward-EBITDA | -0.98 | |||||
| EV-to-FCF | -1.44 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
| Price-to-Net-Cash | 1.43 | |||||
| Earnings Yield (Greenblatt) % | -106.38 | |||||
| FCF Yield % | -18.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TERN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Terns Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.27 | ||
| Beta | -0.55 | ||
| Volatility % | 84.2 | ||
| 14-Day RSI | 51.43 | ||
| 14-Day ATR ($) | 0.416018 | ||
| 20-Day SMA ($) | 5.1105 | ||
| 12-1 Month Momentum % | -59.62 | ||
| 52-Week Range ($) | 3.26 - 13.2252 | ||
| Shares Outstanding (Mil) | 64.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Terns Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Terns Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Terns Pharmaceuticals Inc Frequently Asked Questions
What is Terns Pharmaceuticals Inc(TERN)'s stock price today?
The current price of TERN is $5.56. The 52 week high of TERN is $13.23 and 52 week low is $3.26.
When is next earnings date of Terns Pharmaceuticals Inc(TERN)?
The next earnings date of Terns Pharmaceuticals Inc(TERN) is 2024-05-15 Est..
Does Terns Pharmaceuticals Inc(TERN) pay dividends? If so, how much?
Terns Pharmaceuticals Inc(TERN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers